A Randomized, Double-Blind, Placebo-Controlled, Multicenter Efficacy and Safety Study of Toremifene for the Prevention of Prostate Cancer in Men With High-Grade Prostatic Intraepithelial Neoplasia (PIN)
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Toremifene (Primary)
- Indications Prostate cancer; Prostatic intraepithelial neoplasia
- Focus Registrational; Therapeutic Use
- 07 Jan 2013 Primary endpoint 'Disease-occurrence-rate' has not been met.
- 07 Jan 2013 Primary endpoint 'Disease-free-survival-rate' has not been met.
- 19 May 2011 Results presented at the 106th Annual Meeting of the American Urological Association.